VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
BOD Resolutions
IMP - Resolution of the BOD at the 1st meeting for the term of 2023-2027
04/29/2023
IMP - BOD Resolution No. 09 dated May 23, 2024 re. the implementation of dividend payments in 2023
05/24/2024
IMP - BOD Resolution No. 08 dated May 23, 2024 re. the appointment of Audit Committee member
05/24/2024
IMP - BOD Resolution No. 07 dated May 23, 2024 approving the receipt of credit limits from commercial banks in 2024
05/24/2024
IMP - BOD Resolution No. 06 dated May 23, 2024 re. the selection of auditing firm in 2024
05/24/2024
IMP - Resolution of the BOD at the regular meeting on February 23, 2024
02/24/2024